HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study.

AbstractBACKGROUND:
Full-thickness macular holes generally cause a significant reduction in visual acuity, due in part to a rim of surrounding neurosensory retinal detachment and retinal thickening. Recent studies have suggested that flattening of this narrow rim of neurosensory detachment can result in improved visual acuity. However, the ability to flatten the neurosensory detachment is limited using current surgical techniques.
METHODS:
Transforming growth factor-beta 2 (TGF-beta 2) is a recently discovered potent stimulator of wound healing. The authors, therefore, performed a prospective randomized study of 60 patients to determine if the local application of TGF-beta 2 to the edge of the macular hole can reproducibly induce flattening of the surrounding neurosensory detachment. The results of a study designed to determine the effect of a pars plana vitrectomy, fluid-gas exchange, and intravitreal instillation of TGF-beta 2 in eyes with a full-thickness macular hole and reduced visual acuity are reported.
RESULTS:
After treatment, visual acuity improved 2 lines or more in 5 of 11 eyes treated with 70 ng, in 4 of 12 eyes treated with 330 ng, and in 10 of 11 eyes treated with 1330 ng of TGF-beta 2. In some eyes, hyaluronic acid was added. In these cases, visual acuity improved 2 lines or more in 0 of 9 eyes treated with 70 ng TGF-beta 2, in 2 of 8 eyes treated with 330 ng, and in 4 of 9 eyes treated with 1330 ng.
CONCLUSION:
Logistic regression analysis demonstrated a statistically significant beneficial effect of TGF-beta 2 on visual improvement (P = 0.003).
AuthorsB M Glaser, R G Michels, B D Kuppermann, R N Sjaarda, R A Pena
JournalOphthalmology (Ophthalmology) Vol. 99 Issue 7 Pg. 1162-72; discussion 1173 (Jul 1992) ISSN: 0161-6420 [Print] United States
PMID1495798 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Transforming Growth Factor beta
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Female
  • Fluorescein Angiography
  • Fundus Oculi
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Retinal Detachment (therapy)
  • Retinal Perforations (physiopathology, surgery, therapy)
  • Transforming Growth Factor beta (therapeutic use)
  • Visual Acuity
  • Vitrectomy
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: